Partner announcement

Markwell Clarizio LLP welcomes Dino Clarizio as a partner

Markwell Clarizio LLP is pleased to announce that prominent IP lawyer, Dino Clarizio, has joined the partnership as of October 2, 2023.

October 2, 2023

Dino has practised exclusively in the field of intellectual property law for more than 30 years.  His practice focuses on all aspects of patent law in Canada, including the law relating to claim construction, infringement, remedies, anticipation, obviousness, and other invalidity issues, and has acted as counsel in IP litigation for a variety of different clients, from sole inventors to Fortune 500 companies.

Dino has also been counsel on trademark cases involving issues such as confusion, depreciation of goodwill, trade dress infringement, functionality and survey evidence.

Dino is recognized as a leading IP lawyer by Lexpert, Chambers, The Legal 500 Canada, Best Lawyers in Canada, Who’s Who Legal Canada, Euromoney, IAM Patent 1000, and Managing Intellectual Property’s IP Stars for patents.

He is also a registered patent agent in both Canada and the U.S., and a registered trademark agent in Canada.

To learn more about our team of professionals, click here.

Markwell Clarizio LLP

Markwell Clarizio LLP

Markwell Clarizio LLP is a Canadian law firm with extensive experience in intellectual property litigation and regulatory issues impacting the life sciences industry. The firm helps clients navigate the complex regulatory system governing the approval and sale of health products in Canada, including data protection, patent linkage, patent term restoration, pricing, formulary interchangeability, and product listing agreements. Its counsel attend meetings with regulators and appear as counsel at hearings before the Patented Medicine Prices Review Board and judicial review applications. Markwell Clarizio represents clients in patent infringement and impeachment actions, trademark infringement and opposition proceedings, injunction motions, appeals, interventions, and cases under the Patented Medicines (Notice of Compliance) Regulations.

View All Announcements by This Firm

Recent lawyer announcements